These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12381968)

  • 21. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
    Delmas PD; McClung MR; Zanchetta JR; Racewicz A; Roux C; Benhamou CL; Man Z; Eusebio RA; Beary JF; Burgio DE; Matzkin E; Boonen S
    Bone; 2008 Jan; 42(1):36-42. PubMed ID: 17920005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it].
    MMW Fortschr Med; 2003 Feb; 145(8):55. PubMed ID: 12661447
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diphosphonates in the treatment of osteoporosis].
    Papapoulos SE; Lockefeer JH
    Ned Tijdschr Geneeskd; 1991 Mar; 135(13):553-6. PubMed ID: 1902912
    [No Abstract]   [Full Text] [Related]  

  • 24. Periodontal assessment of postmenopausal women receiving risedronate.
    Palomo L; Bissada NF; Liu J
    Menopause; 2005; 12(6):685-90. PubMed ID: 16278611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risedronate: a new bisphosphonate for the treatment of osteoporosis.
    Kessenich CR
    Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of postmenopausal osteoporosis with etidronate.
    Heyneman CA
    Ann Pharmacother; 1993 Oct; 27(10):1200-1. PubMed ID: 8251688
    [No Abstract]   [Full Text] [Related]  

  • 27. Conference report--scientific and clinical developments in osteoporosis.
    Lindsay R
    Medscape Womens Health; 1999 Nov; 4(6):1. PubMed ID: 10629069
    [No Abstract]   [Full Text] [Related]  

  • 28. Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study.
    Racewicz AJ; Schofield PJ; Cahall DL; Cline GA; Burgio DE
    Curr Med Res Opin; 2007 Dec; 23(12):3079-89. PubMed ID: 17971285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of osteoporosis.
    Lloyd M
    Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
    [No Abstract]   [Full Text] [Related]  

  • 30. In brief: delayed-release risedronate (Atelvia).
    Med Lett Drugs Ther; 2011 Mar; 53(1360):24. PubMed ID: 21412209
    [No Abstract]   [Full Text] [Related]  

  • 31. Medications for postmenopausal osteoporosis prevention.
    Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
    [No Abstract]   [Full Text] [Related]  

  • 32. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Marketing--alendronate versus risedronate].
    Høiseth A
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1386. PubMed ID: 15909030
    [No Abstract]   [Full Text] [Related]  

  • 34. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
    MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169
    [No Abstract]   [Full Text] [Related]  

  • 35. Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.
    Hooper MJ; Ebeling PR; Roberts AP; Graham JJ; Nicholson GC; D'Emden M; Ernst TF; Wenderoth D
    Climacteric; 2005 Sep; 8(3):251-62. PubMed ID: 16390757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].
    MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?].
    Thomas T; Reach G; Lespessailles E
    Rev Prat; 2006 Jan; Spec No():3-11. PubMed ID: 16502833
    [No Abstract]   [Full Text] [Related]  

  • 38. Bisphosphonates for osteoporosis.
    Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
    Trémollières F
    Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
    [No Abstract]   [Full Text] [Related]  

  • 40. Risedronate-induced Hepatitis.
    Phillips MB
    Am J Med; 2007 Mar; 120(3):e1-2. PubMed ID: 17349419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.